Literature DB >> 25196590

Prenatal diagnosis in haemophilia A: experience of the genetic diagnostic laboratory.

L Kessler1, R Adams, L Mighion, S Walther, A Ganguly.   

Abstract

The paper describes the experience of the Genetic Diagnostic Laboratory in prenatal testing for haemophilia A, an X-linked recessive disease caused by mutations in the F8 gene. Knowledge of a familial mutation prior to pregnancy can benefit prenatal diagnosis and decrease wait time for molecular testing during pregnancy. This is a retrospective review of a series of pregnant women who pursued F8 gene testing from December 1997 through May 2012, highlighting three cases, which demonstrate the technical complexities of analysis and the implications of not knowing carrier status prior to pregnancy. Mutations of the F8 gene were detected in affected males, obligate female carriers and suspected female carriers by DNA sequencing, inverse-PCR, qRT-PCR, Southern blot and exonic dosage analysis. The same methods were used to analyse prenatal samples from obligate or suspected female carriers upon request. Maternal cell contamination studies were performed for all prenatal samples analysed. Ninety-nine women pursued F8 testing during pregnancy, either for carrier status alone or carrier status and prenatal diagnosis. Ninety-one women (91%) requested carrier testing because they did not know their F8 mutation carrier status prior to pregnancy. Eight women requested prenatal diagnosis only, and only 4 of these were aware of their mutation status. Thirty-seven individuals were found to be mutation carriers. Forty-two prenatal samples were received for prenatal diagnosis. In total 21 foetuses were identified as mutation carriers. Mutation detection was complex and increased the turnaround time in some cases. Only four of 99 women who submitted samples for F8 testing were aware of their F8 mutation status prior to pregnancy. Knowledge of F8 mutation status prior to pregnancy allows for efficient prenatal diagnosis, when desired. Thus, preconception genetic counselling is required to inform patients of the available options and the complex and time-consuming nature of F8 testing.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  factor VIII mutations; genetic counselling; haemophilia A; prenatal diagnosis

Mesh:

Substances:

Year:  2014        PMID: 25196590     DOI: 10.1111/hae.12517

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

1.  Haemophilia A: the consequences of de novo mutations. Two case reports.

Authors:  Federica Zarrilli; Antonio Coppola; Michele Schiavulli; Ernesto Cimino; Ausilia Elce; Giuseppe Rescigno; Giuseppe Castaldo; Felice Amato
Journal:  Blood Transfus       Date:  2017-04-05       Impact factor: 3.443

2.  Evaluation of factor VIII polymorphic short tandem repeat markers in linkage analysis for carrier diagnosis of hemophilia A.

Authors:  Sabina Shrestha; Sufang Dong; Zuhua Li; Zhuliang Huang; Fang Zheng
Journal:  Biomed Rep       Date:  2016-07-04

3.  11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.

Authors:  Elise M Fiala; Michael V Ortiz; Jennifer A Kennedy; Dominik Glodzik; Megan Harlan Fleischut; Kelly A Duffy; Evan R Hathaway; Todd Heaton; Justin T Gerstle; Peter Steinherz; Neerav Shukla; Nicole McNeer; Kaitlyn Tkachuk; Nancy Bouvier; Karen Cadoo; Maria I Carlo; Alicia Latham; Marianne Dubard Gault; Vijai Joseph; Yelena Kemel; Alex Kentsis; Zsofia Stadler; Michael La Quaglia; Elli Papaemmanuil; Danielle Friedman; Arupa Ganguly; Andrew Kung; Kenneth Offit; Jennifer M Kalish; Michael F Walsh
Journal:  Cancer       Date:  2020-04-22       Impact factor: 6.860

4.  Improved molecular detection of mosaicism in Beckwith-Wiedemann Syndrome.

Authors:  Samuel W Baker; Kelly A Duffy; Jennifer Richards-Yutz; Matthew A Deardorff; Jennifer M Kalish; Arupa Ganguly
Journal:  J Med Genet       Date:  2020-05-19       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.